financetom
Business
financetom
/
Business
/
Fluor Secures Final Approval for Reko Diq Copper Project in Pakistan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fluor Secures Final Approval for Reko Diq Copper Project in Pakistan
Jul 29, 2025 3:03 AM

05:43 AM EDT, 07/29/2025 (MT Newswires) -- Fluor (FLR) said Monday it received final notice to proceed from Barrick Mining for the Reko Diq copper-gold project in Balochistan, Pakistan.

The company was selected as the lead engineering, procurement, and construction management partner in April and recognized its share of the undisclosed contract in Q2, it said.

The project is expected to create jobs, drive economic growth in Balochistan, and support long-term regional development programs, Fluor said.

Barrick said the Reko Diq mine will operate as a large truck-and-shovel open pit with multiple pits, processing facilities, and supporting transport infrastructure, targeting first production in 2028.

Fluor added that the site will eventually reach a total throughput of 90 million tonnes per year and has a projected life of over 40 years.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Acm Research Insider Sold Shares Worth $286,800, According to a Recent SEC Filing
Acm Research Insider Sold Shares Worth $286,800, According to a Recent SEC Filing
Nov 26, 2024
04:38 PM EST, 11/26/2024 (MT Newswires) -- Haiping Dun, Director, on November 22, 2024, sold 15,000 shares in Acm Research ( ACMR ) for $286,800. Following the Form 4 filing with the SEC, Dun has control over a total of 874,148 shares of the company, with 774,148 shares held directly and 100,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1680062/000114036124047888/xslF345X05/form4.xml ...
PTC Therapeutics' ALS drug fails mid-stage trial
PTC Therapeutics' ALS drug fails mid-stage trial
Nov 26, 2024
Nov 26 (Reuters) - PTC Therapeutics ( PTCT ) said on Tuesday its drug did not meet the main goal in a mid-stage trial evaluating it in patients with a type of fatal neurodegenerative disease called amyotrophic lateral sclerosis. ...
Cencora Insider Sold Shares Worth $12,198,750, According to a Recent SEC Filing
Cencora Insider Sold Shares Worth $12,198,750, According to a Recent SEC Filing
Nov 26, 2024
04:38 PM EST, 11/26/2024 (MT Newswires) -- Steven H Collis, Director, Executive Chairman, on November 25, 2024, sold 50,000 shares in Cencora ( COR ) for $12,198,750. Following the Form 4 filing with the SEC, Collis has control over a total of 326,557 shares of the company, with 326,557 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1140859/000114085924000179/xslF345X05/wk-form4_1732656706.xml ...
HP Fiscal Q4 Non-GAAP Earnings, Revenue Rise -- Shares Drop After Hours
HP Fiscal Q4 Non-GAAP Earnings, Revenue Rise -- Shares Drop After Hours
Nov 26, 2024
04:41 PM EST, 11/26/2024 (MT Newswires) -- HP (HPQ) reported fiscal Q4 non-GAAP diluted earnings late Tuesday of $0.93, up from $0.90 a year earlier. Analysts polled by FactSet expected $0.93. Revenue for the quarter ended Oct. 31 was $14.06 billion, up from $13.82 billion a year earlier. Analysts surveyed by FactSet expected $13.99 billion. The company said it expects...
Copyright 2023-2026 - www.financetom.com All Rights Reserved